Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus.
about
Anion Gap Toxicity in Alloxan Induced Type 2 Diabetic Rats Treated with Antidiabetic Noncytotoxic Bioactive Compounds of Ethanolic Extract of Moringa oleiferaApplication of pharmacometric approaches to evaluate effect of weight and renal function on pharmacokinetics of alogliptinThe pharmacokinetics and pharmacodynamics of alogliptin in children, adolescents, and adults with type 2 diabetes mellitus.Fixed-dose combination of alogliptin/pioglitazone improves glycemic control in Japanese patients with type 2 diabetes mellitus independent of body mass index.Incretin manipulation in diabetes management.
P2860
Alogliptin in combination with metformin and pioglitazone for the treatment of type 2 diabetes mellitus.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Alogliptin in combination with ...... t of type 2 diabetes mellitus.
@ast
Alogliptin in combination with ...... t of type 2 diabetes mellitus.
@en
type
label
Alogliptin in combination with ...... t of type 2 diabetes mellitus.
@ast
Alogliptin in combination with ...... t of type 2 diabetes mellitus.
@en
prefLabel
Alogliptin in combination with ...... t of type 2 diabetes mellitus.
@ast
Alogliptin in combination with ...... t of type 2 diabetes mellitus.
@en
P2860
P356
P1476
Alogliptin in combination with ...... t of type 2 diabetes mellitus.
@en
P2093
Daniel Q Holland
Joshua J Neumiller
P2860
P304
P356
10.2147/DMSO.S37648
P577
2014-07-03T00:00:00Z